225 related articles for article (PubMed ID: 1423179)
1. Lipid-associated sialic acid, squamous cell carcinoma antigen, carcinoembryonic antigen, and lactic dehydrogenase levels as tumor markers in squamous cell carcinoma of the head and neck.
Dreyfuss AI; Clark JR; Andersen JW
Cancer; 1992 Nov; 70(10):2499-503. PubMed ID: 1423179
[TBL] [Abstract][Full Text] [Related]
2. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
[TBL] [Abstract][Full Text] [Related]
3. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid, and CA-125.
Straka MB; Wagner RL; Johnson JT; Kachman KK; Eibling DE
Arch Otolaryngol Head Neck Surg; 1992 Aug; 118(8):802-5. PubMed ID: 1642830
[TBL] [Abstract][Full Text] [Related]
4. Use of tumor markers in the management of head and neck cancer.
Rosati G; Riccardi F; Tucci A
Int J Biol Markers; 2000; 15(2):179-83. PubMed ID: 10883893
[TBL] [Abstract][Full Text] [Related]
5. Serum SCC-Ag in head and neck squamous cell carcinoma.
Palermo F; Carniato A; Fede A; Boccaletto F; Marchiori C
Int J Biol Markers; 1990; 5(3):118-20. PubMed ID: 2286775
[TBL] [Abstract][Full Text] [Related]
6. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma.
Kimura Y; Fujieda S; Takabayashi T; Tanaka T; Sugimoto C; Saito H
Cancer Lett; 2000 Jul; 155(2):163-8. PubMed ID: 10822131
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.
Body JJ; Sculier JP; Raymakers N; Paesmans M; Ravez P; Libert P; Richez M; Dabouis G; Lacroix H; Bureau G
Cancer; 1990 Apr; 65(7):1552-6. PubMed ID: 2311066
[TBL] [Abstract][Full Text] [Related]
8. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
9. Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck.
Ogawa T; Tsurusako Y; Kimura N; Nishioka S; Akagi H; Nishizaki K; Nishioka K; Rutka J
Acta Otolaryngol Suppl; 1999; 540():72-6. PubMed ID: 10445084
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of a panel of tumor markers as prognostic factors in patients with squamous cell carcinoma of head and neck.
Kandiloros D; Eleftheriadou A; Chalastras T; Kyriou L; Yiotakis I; Ferekidis E
Med Oncol; 2006; 23(4):463-70. PubMed ID: 17303904
[TBL] [Abstract][Full Text] [Related]
12. Squamous cell carcinoma antigen and protein-bound sialic acid in the management of head and neck cancer.
Bhatavdekar JM; Patel DD; Vora HH; Balar DB
Int J Biol Markers; 1991; 6(4):237-40. PubMed ID: 1795131
[TBL] [Abstract][Full Text] [Related]
13. Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).
Makrantonakis P; Pectasides D; Aggouridakis C; Visvikis A; Daniilidis J; Fountzilas G
Am J Clin Oncol; 1999 Dec; 22(6):542-9. PubMed ID: 10597736
[TBL] [Abstract][Full Text] [Related]
14. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of SCC antigen in the serum of patients with head and neck cancer.
Molina R; Torres MD; Moragas M; Perez-Villa J; Filella X; Jo J; Farrus B; Giménez N; Traserra J; Ballesta AM
Tumour Biol; 1996; 17(2):81-9. PubMed ID: 8658017
[TBL] [Abstract][Full Text] [Related]
16. Circulating markers in squamous cell carcinoma of the head and neck: a review.
Rassekh CH; Johnson JT; Eibling DE
Eur J Cancer B Oral Oncol; 1994 Jan; 30B(1):23-8. PubMed ID: 9135969
[TBL] [Abstract][Full Text] [Related]
17. Use of serum markers in the diagnosis and management of laryngeal cancer.
Mevio E; Benazzo M; Galioto P; Spriano P; Pizzala R
Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):90-2. PubMed ID: 2032368
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of tumor markers in head and neck squamous cell carcinomas].
Yoneda K; Hirota J; Yamamoto T; Ueta E; Osaki T
Gan No Rinsho; 1990 Mar; 36(4):458-64. PubMed ID: 2181163
[TBL] [Abstract][Full Text] [Related]
19. Tumor markers in the diagnosis and follow-up of head and neck cancer: role of CEA, CA 19-9, SCC, TK, and dTTPase.
Walther EK; Dahlmann N; Gorgulla HT
Head Neck; 1993; 15(3):230-5. PubMed ID: 8387981
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of the usefulness of CYFRA 21-1 as a tumor marker in squamous cell carcinomas of the head and neck].
Sano K; Kataoka S; Katoh T; Kawauchi H; Morikawa S
Nihon Jibiinkoka Gakkai Kaiho; 1997 Jul; 100(7):790-7. PubMed ID: 9277101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
